Related Experiment Videos
Rheumatic features of sarcoidosis
1Department of Medicine, University of Helsinki, Finland.
Current Opinion in Rheumatology
|January 1, 1997
Summary
Sarcoidosis pathogenesis involves T lymphocytes and macrophages, leading to granulomatous lesions. Musculoskeletal symptoms are common, and methotrexate may treat chronic cases.
Area of Science:
- Immunology
- Pathogenesis of Sarcoidosis
Background:
- Recent studies reveal interactions between alveolar T lymphocytes and macrophages in sarcoidosis pathogenesis.
- Activated CD4+ T helper 1 cells and macrophages trigger cytokine cascades, causing lymphocytic alveolitis and granulomatous lesions.
Purpose of the Study:
- To elucidate the immunopathogenesis of sarcoidosis.
- To highlight the clinical features and musculoskeletal manifestations of sarcoidosis.
- To discuss therapeutic options for refractory cases.
Main Methods:
- Analysis of T lymphocyte-macrophage interactions in the alveoli.
- Characterization of T cell receptor gene segment expression.
- Review of clinical and pathological findings.
Main Results:
- Specific T lymphocyte subpopulations with restricted T cell receptor expression suggest an antigen-driven process.
- Sarcoidosis clinical features can mimic rheumatic diseases, with increasing reports of autoimmune disease coexistence.
- Musculoskeletal manifestations include arthritis, myopathy, and osseous lesions.
Conclusions:
- The pathogenesis of sarcoidosis is linked to T lymphocyte and macrophage interactions.
- Musculoskeletal sarcoidosis requires careful diagnosis due to overlapping symptoms with rheumatic diseases.
- Low-dose methotrexate is a potential treatment for chronic or refractory musculoskeletal sarcoidosis.